Gary W. Pace

CIK: 0001184778

Transaction Breakdown

Open Market Buys (P)6 (75.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRDF

Cardiff Oncology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

CRDF
Cardiff Oncology, Inc.
Jul 14, 2026
Purchase(P)
Direct
687.3K shares at avg. $1.46$1000K
CRDF
Cardiff Oncology, Inc.
Jun 18, 2026
Purchase(P)
Direct
30K shares at avg. $1.22$37K
CRDF
Cardiff Oncology, Inc.
Jun 11, 2026
Award(A)
Stock Options
Direct
40.6K shares-
CRDF
Cardiff Oncology, Inc.
Jul 30, 2025
Purchase(P)
Direct
275K shares at avg. $2.45$674K
CRDF
Cardiff Oncology, Inc.
Jul 30, 2025
Purchase(P)
Indirect
15K shares at avg. $2.45$37K
CRDF
Cardiff Oncology, Inc.
Jun 26, 2025
Award(A)
Stock Options
Direct
40.6K shares-
CRDF
Cardiff Oncology, Inc.
Dec 11, 2024
Purchase(P)
Indirect
11.5K shares at avg. $2.60$30K
CRDF
Cardiff Oncology, Inc.
Dec 11, 2024
Purchase(P)
Direct
350.1K shares at avg. $2.60$910K

		Type	Shares	Price		Ownership
Jul 14, 2026	CRDF Cardiff Oncology, Inc.	Purchase(P)	687,285	$1.46	$1,000,000	Direct
Jun 18, 2026	CRDF Cardiff Oncology, Inc.	Purchase(P)	30,000	$1.22	$36,600	Direct
Jun 11, 2026	CRDF Cardiff Oncology, Inc.	Award(A) Stock Options	40,565	-	-	Direct
Jul 30, 2025	CRDF Cardiff Oncology, Inc.	Purchase(P)	275,000	$2.45	$673,750	Direct
Jul 30, 2025	CRDF Cardiff Oncology, Inc.	Purchase(P)	15,000	$2.45	$36,750	Indirect
Jun 26, 2025	CRDF Cardiff Oncology, Inc.	Award(A) Stock Options	40,565	-	-	Direct
Dec 11, 2024	CRDF Cardiff Oncology, Inc.	Purchase(P)	11,500	$2.60	$29,900	Indirect
Dec 11, 2024	CRDF Cardiff Oncology, Inc.	Purchase(P)	350,115	$2.60	$910,299	Direct

1-8 of 8 transactions

About PACE GARY W

PACE GARY W (SEC CIK 0001184778) files insider reports with the SEC as Director of Cardiff Oncology, Inc. (CRDF).

Signal8 holds 6 ownership filings by PACE GARY W, all Form 4s, filed between Dec 12, 2024 and Jul 16, 2026. Those filings report 8 transactions, from Dec 11, 2024 to Jul 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on PACE GARY W's filings is in SAN DIEGO, CA.

Recent filings by PACE GARY W

Jul 14, 2026: Open-market purchase of CRDF shares (Form 4, code P).
Jun 18, 2026: Open-market purchase of CRDF shares (Form 4, code P).
Jun 11, 2026: Grant or award of CRDF derivative securities (Form 4, code A).
Jul 30, 2025: Open-market purchases of CRDF shares (2 lines, Form 4, code P).
Jun 26, 2025: Grant or award of CRDF derivative securities (Form 4, code A).

Other insiders filing for Cardiff Oncology, Inc. (CRDF)

Alland Leila, Chief Medical Officer
Mohindru Mani, Chief Executive Officer
Armitage James O, Director
White Lale, Director
TANNENBAUM RENEE P, Director
Markin Rodney S, Director

How to read Form 4 transaction codes